This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Ondansetron ODT 4 mg tablets, a medication used to treat nausea and vomiting. The contract has a ceiling value of $13,937.41 and a completion date of February 20, 2025. It is a firm fixed-price contract, with no set-aside designation. AmerisourceBergen holds a significant...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Ondansetron ODT 4 mg tablets, a medication commonly used to treat nausea and vomiting. The contract has a ceiling value of $1,724.85 and a period of performance through March 6, 2024. It is a firm-fixed-price contract, with no set-aside designation. AmerisourceBergen holds a larger...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Ondansetron ODT 4 mg tablets, a medication used to treat nausea and vomiting. The contract has a ceiling value of $16,001.05 and runs through March 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ondansetron ODT 4 mg tablets, a medication used to treat nausea and vomiting. The contract has a ceiling value of $2,586.96 and a completion date of January 21, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen holds a...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Ondansetron ODT 4 mg tablets, a medication used to treat nausea and vomiting. The contract has a ceiling value of $4,943.11 and a performance period through May 8, 2025. It is a Firm Fixed Price contract, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a substantial...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Ondansetron ODT 4 MG tablets, a medication used to treat nausea and vomiting. The contract has a ceiling value of $3,895.77 and a period of performance through January 28, 2025. It is a firm-fixed-price contract, with no set-aside designation. AmerisourceBergen has a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ondansetron ODT 4 mg tablets, a medication used to treat nausea and vomiting. The contract has a ceiling value of $2,050.14 and is a firm fixed-price, delivery order contract with a completion date of March 18, 2025. This contract is not set aside for any specific business type....
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Ondansetron ODT 4 mg tablets, a medication used to treat nausea and vomiting. The contract has a firm fixed price and a ceiling value of $63,232.11, with a performance period ending on May 2, 2025. This contract is not set aside and is an open competition. AmerisourceBergen...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Ondansetron ODT 4 mg tablets, a medication used to treat nausea and vomiting. The contract has a ceiling value of $11,976.96 and a period of performance through April 1, 2025. It is a firm-fixed-price delivery order contract, with no set-aside designation. AmerisourceBergen holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Ondansetron ODT 4 mg tablets, a medication used to treat nausea and vomiting. The total ceiling value of the contract is $8,052.76, and it has a period of performance through May 8, 2025. The contract is a firm fixed-price delivery order, without any set-aside designation, indicating open competition....